EcoDrugPlus

Presenilin-2-Like

Ensembl ID : ENSCGOG00000012020
Gene Symbol: LOC115006185
3 Cross references
206 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSCGOG00000000902
Gene Symbol: LOC115011963
3 Cross references
400 Possible Orthologues:

Primary Amine Oxidase, Lung Isozyme-Like

Ensembl ID : ENSCGOG00000000901
Gene Symbol: LOC115011856
2 Cross references
364 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSCGOG00000010949
Gene Symbol: LOC115016094
3 Cross references
250 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSCGOG00000016157
Gene Symbol: LOC115027770
3 Cross references
257 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSCGOG00000005236
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCGOG00000005710
Gene Symbol: PTGDR2
1 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCGOG00000019845
Gene Symbol: PTGDR2
3 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2b (Subtype Ep2)

Ensembl ID : ENSCGOG00000004108
Gene Symbol: PTGER2B
1 Cross references
172 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCGOG00000023021
Gene Symbol: PTGER3
3 Cross references
196 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSCGOG00000004215
Gene Symbol: LOC115012404
3 Cross references
163 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSCGOG00000016549
Gene Symbol: LOC115011217
3 Cross references
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).